Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Manabu Date"'
Autor:
Koji Teramoto, Hiroyasu Yokomise, Shinichiro Hashimoto, Shoko Norimura, Naomi Fujiwara-Honjo, Nozomi Hashimoto, Kana Kuraishi, Manabu Date, Masahiro Ohtani, Keiichi Kontani
Publikováno v:
Oncologie. 23:229-239
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::648358965640d55fda7b32bf302b542c
https://doi.org/10.32604/oncologie.2021.016277
https://doi.org/10.32604/oncologie.2021.016277
Autor:
Chisa, Murazawa, Keiichi, Kontani, Shinichiro, Hashimoto, Nozomi, Hashimoto, Shoko, Norimura, Masahiro, Ohtani, Manabu, Date, Hiroyasu, Yokomise
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 46(9)
We report 4 female patients with metastatic breast cancer who were administered TS-1 as a late-line treatment and showed favorable outcomes. Their average age was 66.3. The patients, all of whom had undergone prior treatment with both anthracyclines
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dc89c7643d0b867f9dc1f59100dc0d14
https://pubmed.ncbi.nlm.nih.gov/31530791
https://pubmed.ncbi.nlm.nih.gov/31530791
Autor:
Naomi Fujiwara-Honjo, Manabu Date, Shoko Norimura, Hitoshi Houchi, Shinichiro Hashimoto, Masahiro Ohtani, Hiroyasu Yokomise, Keiichi Kontani, Hiroaki Tanaka, Koji Teramoto, Chisa Murazawa
Publikováno v:
Molecular and Clinical Oncology. 4:947-953
The survival of patients with metastatic breast cancer (MBC) has not improved, despite recent advances in therapeutic strategies. This is mainly due to the fact that cytotoxic agents cannot be administered over a long period, even if they exhibit fav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96b22575c3f7de48a8d81d22c19b6291
https://doi.org/10.3892/mco.2016.841
https://doi.org/10.3892/mco.2016.841
Autor:
Keiichi Kontani, Kana Kuraishi, Shin-ichiro Hashimoto, Shoko Norimura, Nozomi Hashimoto, Masahiro Ohtani, Naomi Fujiwara-Honjo, Manabu Date, Koji Teramoto, Hiroyasu Yokomise
Publikováno v:
Oncologie (Tech Science Press); 2021, Vol. 23 Issue 2, p229-239, 11p
Autor:
Naomi Fujiwara-Honjo, Reiji Haba, Chisa Murazawa, Masahiro Ohtani, Keiichi Kontani, Hiroaki Tanaka, Yoshio Kushida, Manabu Date, Hitoshi Houchi, Shinichiro Hashimoto, Akira Yamauchi, Noriyuki Kuroda, Shoko Norimura, Hiroyasu Yokomise
Publikováno v:
Cancer Biology & Therapy. 14:20-28
We assessed the clinical usefulness of human epidermal growth factor receptor-2 extracellular domain (HER2ECD) as a biomarker for detecting cancer and monitoring disease status and for predicting the efficacy of anticancer treatment in breast cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d9ac916e76debfe4d6091cc5abe77e9
https://doi.org/10.4161/cbt.22626
https://doi.org/10.4161/cbt.22626
Autor:
Masahiro Ohtani, Chisa Murazawa, Keiichi Kontani, Shoko Norimura, Hiroaki Tanaka, Hitoshi Houchi, Manabu Date, Shinichiro Hashimoto, Naomi Fujiwara-Honjo, Hiroyasu Yokomise
Publikováno v:
Molecular and Clinical Oncology. 1:225-230
The objective of treatment for metastatic breast cancer (MBC) is to control the disease or disease-related symptoms. Prolonged survival has also often been achieved by chemotherapeutic regimens in this setting. Long-term administration of one therape
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::554ca137675c9874f19fdeef3112f531
https://doi.org/10.3892/mco.2012.49
https://doi.org/10.3892/mco.2012.49
Autor:
Hiroyasu Yokomise, Hiroaki Tanaka, Koji Teramoto, Hitoshi Houchi, Shinichiro Hashimoto, Shoko Norimura, Chisa Murazawa, Masahiro Ohtani, Naomi Fujiwara-Honjo, Manabu Date, Keiichi Kontani
Publikováno v:
World Journal of Surgical Oncology
Background Although survival of patients with metastatic breast cancer (MBC) has been significantly prolonged over the past decade due to improvement of anti-cancer therapeutics, only a few patients survive for more than 10 years. It has not been det
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b3831fa525ccf505255470f0ec87d27
http://europepmc.org/articles/PMC4236407
http://europepmc.org/articles/PMC4236407
Autor:
Katashi Satoh, Junpei Nakagawa, Takahiko Misao, Hideharu Nakano, Manabu Date, Takuya Kobayashi
Publikováno v:
Haigan. 39:197-201
症例は67歳の重喫煙者の男性で, 検診の喀痰細胞診にてD判定を受け当センターを受診した.胸部CTでは左S10に気腫性嚢胞に接した小結節影を認めたが, 経過観察とした.半年後, 検診の喀痰検
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd5d0722b4a59fba8b1aec79e691c739
https://doi.org/10.2482/haigan.39.197
https://doi.org/10.2482/haigan.39.197
Autor:
Michiyo Okane, Emiko Kagawa, Yosuke Yamamoto, Atsuko Takuma, Koji Takebe, Manabu Date, Atsuko Tsuji, Naomi Yasumo
Publikováno v:
The Journal of the Japanese Society of Clinical Cytology. 37:132-136
1990年8月から1996年12月までの6年5ヵ月に超音波検査を併用した乳がん検診において, 3,698症例の4,129病変に乳腺穿刺細胞診が行われた. 細胞診判定はclass I, IIが73.4%, class IIIa 3.1%, class III 0.7%, c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::06f765c003897aeb24085346b5ddb4a9
https://doi.org/10.5795/jjscc.37.132
https://doi.org/10.5795/jjscc.37.132
Publikováno v:
Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening). 4:105-114
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1db36c3bed176821008108a201af3fe8
https://doi.org/10.3804/jjabcs.4.105
https://doi.org/10.3804/jjabcs.4.105